Cardax Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Public

  • Employees
  • 20

Employees

  • Stock Symbol
  • CDXI

Stock Symbol

Cardax General Information

Description

Cardax Inc is a life sciences company engaged in the development of marketing, and distribution of consumer health products in the United States. The firm's platform has applications in arthritis, metabolic syndrome, liver disease, and cardiovascular disease, as well as macular degeneration and prostate disease. It is focused on the development of astaxanthin technologies. The group's product ZanthoSyn is marketed as a novel astaxanthin dietary supplement. Astaxanthin is a clinically studied ingredient with a safe anti-inflammatory activity that supports joint health, cardiovascular health, metabolic health, and liver health. Geographically, it generates maximum revenue from the United States.

Contact Information

Formerly Known As
Koffee Korner
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
PINX
Corporate Office
  • 2800 Woodlawn Drive
  • Suite 129
  • Honolulu, HI 96822
  • United States
+1 (808) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cardax Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
449.80

Cardax Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 5,945 5,525 9,350 26,469
Revenue 501 539 711 1,511
EBITDA (3,026) (2,636) (4,430) (3,991)
Net Income (5,435) (5,056) (5,093) (4,024)
Total Assets 1,378 1,425 2,019 2,459
Total Debt 5,395 4,784 2,597 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Cardax Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cardax‘s full profile, request access.

Request a free trial

Cardax Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Cardax‘s full profile, request access.

Request a free trial

Cardax Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Cardax Inc is a life sciences company engaged in the development of marketing, and distribution of consumer health produ
Drug Discovery
Honolulu, HI
20 As of 2021
000.00
000000 - 000 000.00

000000

lore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco la
000000000000000
Ingelheim Am Rhein, Germany
00000 As of 0000

000000

abore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation
000000000000000
Ireland
000 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cardax Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Boehringer Ingelheim Corporation Ingelheim Am Rhein, Germany 00000
Amarin Corporation Ireland 000 00000 000000 - 000 00000
Acasti Pharma Corporation Princeton, NJ 00 000.00 000000000 000.00
Astellas Pharma Corporation Tokyo, Japan 00000 00000000
AbbVie Corporation North Chicago, IL 00000 000.00 000000000 000.00
You’re viewing 5 of 10 competitors. Get the full list »

Cardax Executive Team (6)

Name Title Board Seat Contact Info
David Watumull Co-Founder, Chairman & Chief Executive Officer
David Watumull Chief Operating Officer & Chief Financial Officer
John Russell Chief Financial Officer
Paresh Soni MD Executive
You’re viewing 4 of 6 executive team members. Get the full list »

Cardax Board Members (7)

Name Representing Role Since
David Watumull Cardax Co-Founder, Chairman & Chief Executive Officer 000 0000
Elona Kogan JD Self Board Member 000 0000
George Bickerstaff III Self Chairman 000 0000
Michele Galen JD Cardax Board Member 000 0000
Terence Kelly Ph.D Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Cardax Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cardax Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Cardax‘s full profile, request access.

Request a free trial

Cardax FAQs

  • When was Cardax founded?

    Cardax was founded in 2006.

  • Who is the founder of Cardax?

    David Watumull is the founder of Cardax.

  • Who is the CEO of Cardax?

    David Watumull is the CEO of Cardax.

  • Where is Cardax headquartered?

    Cardax is headquartered in Honolulu, HI.

  • What is the size of Cardax?

    Cardax has 20 total employees.

  • What industry is Cardax in?

    Cardax’s primary industry is Drug Discovery.

  • Is Cardax a private or public company?

    Cardax is a Public company.

  • What is Cardax’s stock symbol?

    The ticker symbol for Cardax is CDXI.

  • What is Cardax’s current revenue?

    The trailing twelve month revenue for Cardax is $501K.

  • Who are Cardax’s competitors?

    Boehringer Ingelheim, Amarin, Acasti Pharma, Astellas Pharma, and AbbVie are some of the 10 competitors of Cardax.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »